BOULDER, Colo.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care solutions, will launch the Covidien Nellcor™ Bedside SpO2 Patient Monitoring System at the European Society of Anesthesiology Congress, held in Paris June 9-12. The respiratory monitoring platform carries the CE Mark and is now available throughout the European Economic Area (EEA).
The Nellcor Bedside SpO2 System with OxiMax™ technology continuously monitors oxygen saturation (SpO2 ) and pulse rate for adult, pediatric and neonatal patients. The monitoring system gives clinicians instant access to comprehensive trending respiratory information, enabling them to detect subtle yet critical variations and respiratory complications earlier and to intervene sooner. The system features enhanced digital signal processing for precise SpO2 readings during low perfusion or other challenging conditions. It also incorporates SatSeconds™ alarm management technology to differentiate between serious and minor events and reduce clinically insignificant oxygen desaturation alarms. The monitor further offers an intuitive, multicolor screen that is easy to read in any light and from many angles. Hospital technicians can set institutional defaults, replace the battery, perform diagnostics and generally maintain the monitor within the hospital, saving time and resources.
“We are pleased to launch the new Covidien Nellcor Bedside SpO2 Patient Monitoring System,” said Dr. Carmen Walbert MD, Vice President of Medical Affairs, EMEA, Covidien Respiratory and Monitoring Solutions. “Healthcare professionals in low-acuity areas of the hospital need critical patient information at their fingertips so they can respond quickly to evolving patient conditions. By giving them ready access to a patient’s respiratory history, the system allows them to focus on delivering efficient, high-quality care, not gathering and managing data.”
The Nellcor Bedside SpO2 Patient Monitoring System meets medical electrical equipment safety standards, including IEC 60601-1:2005, and complies with the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (RoHS) directive for products sold in the EEA.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.